post-stroke seizures
Conditions
Interventions
patients with early-onset post-stroke seizure:Levatiracetam
patients with early-onset post-stroke seizure:Lamotrigine
patients with early-onset post-stroke seizure:Oxcarbazepine
patients with late-onset post-stroke seizure:Levatiracetam
patients with late-onset post-stroke seizure:Lamotrigine
patients with late-onset post-stroke seizure:Oxcarbazepine
patients with late-onset post-stroke seizure:Depakine
patients with early-onset post-stroke seizure:Depakine
Sponsors
Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with recurrent or late-onset epilepsy after stroke; 2. Onset age >=18 years.
Exclusion criteria
Exclusion criteria: (1) patients with a prior diagnosis of epilepsy; (2) patients with secondary ICH or venous infarction; (3) patients whose seizure might be attributed to other potential causes (e.g., brain tumor, intracranial vascular malformation, traumatic brain injury); (4) patients who cannot be completed effectiveness/safety assessment at least for one time; (5) patients who cannot cooperate with recording the seizures or have difficulty to record seizures; (6) patients who disagree to join this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| time to seizure recurrence;NIHSS Score;mRS Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| MMSE??;Moca score;the incidence of refractory epilepsy;HAMA score;HAMD Score;Responder rate of anti-epileptic treatment;The incidence rate of adverse events;seizure-free rate;Mortality;radiomics data; | — |
Countries
China
Contacts
Public ContactXinshi Wang
the First Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed